Dyne Therapeutics (DYN) Shares Issued (2019 - 2026)

Dyne Therapeutics (DYN) has 8 years of Shares Issued data on file, last reported at $4.0 million in Q1 2026.

• On a quarterly basis, Shares Issued fell 55.0% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a 55.0% decrease from a year earlier, with the FY2025 full-year figure at $9.9 million, up 14.16% from the prior year.
• Shares Issued for Q1 2026 stood at $4.0 million, down from $9.9 million in the prior quarter.
• Over the last five years, Shares Issued for DYN reached as high as $9.9 million in Q4 2023 and fell as low as $4.0 million in Q1 2026.
• Historically, Shares Issued has averaged $8.6 million across 5 years, with a median of $8.7 million in 2024.
• Across the five-year window, Shares Issued soared 581.61% in 2022 and slumped 55.0% in 2026, its largest moves.
• Year by year, Shares Issued stood at $9.4 million in 2022, then increased by 5.68% to $9.9 million in 2023, then slipped by 12.44% to $8.7 million in 2024, then climbed by 14.16% to $9.9 million in 2025, then plunged by 59.91% to $4.0 million in 2026.
• Per Business Quant data, the three most recent Shares Issued figures were $4.0 million in Q1 2026, $9.9 million in Q4 2025, and $9.6 million in Q3 2025.